Male Breast Carcinoma Terminated Phase 1 Trials for Pazopanib (DB06589)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00450879Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By SurgeryTreatment